Adam Bluestein, Fast Company, May 11, 2015

Charles Arntzen, a professor at Arizona State University, is the creator of ZMapp, an injectable synthetic serum made of genetically engineered antibodies grown in tobacco plants, which is currently the most promising drug treatment for people infected with Ebola. In 2014, when the virus swept through West Africa, two American health workers became the first human recipients of the experimental drug and they both recovered. […read more]